ec_id stringlengths 8 8 | translator_id stringlengths 10 29 | drugbank_id stringlengths 7 12 ⌀ | drug_name stringlengths 5 40 | target stringlengths 13 13 | disease_name stringlengths 4 144 | on_label bool 2
classes | off_label bool 2
classes | __index_level_0__ int64 10 4.21k |
|---|---|---|---|---|---|---|---|---|
EC:00003 | UNII:7D0YB67S97 | DB01281 | Abatacept | MONDO:0011429 | Juvenile idiopathic arthritis | true | false | 10 |
EC:00003 | UNII:7D0YB67S97 | DB01281 | Abatacept | MONDO:0020546 | acute graft versus host disease | true | false | 11 |
EC:00003 | UNII:7D0YB67S97 | DB01281 | Abatacept | MONDO:0011849 | psoriatic arthritis | true | false | 12 |
EC:00003 | UNII:7D0YB67S97 | DB01281 | Abatacept | MONDO:0008383 | rheumatoid arthritis | true | false | 13 |
EC:00006 | UNII:73SM5SF3OR | DB14973 | Abrocitinib | MONDO:0004980 | atopic eczema | true | false | 14 |
EC:00007 | CHEBI:167707 | DB11703 | Acalabrutinib | MONDO:0100280 | Waldenstrom macroglobulinemia | false | true | 16 |
EC:00008 | CHEBI:51041 | DB00659 | Acamprosate | MONDO:0007079 | Alcohol dependence | true | false | 17 |
EC:00008 | CHEBI:51041 | DB00659 | Acamprosate | MONDO:0002046 | Alcohol abuse | true | false | 18 |
EC:00010 | CHEBI:2379 | DB01193 | Acebutolol | MONDO:0001134 | Essential hypertension | true | false | 19 |
EC:00010 | CHEBI:2379 | DB01193 | Acebutolol | MONDO:0004425 | hyperthyroidism | false | true | 20 |
EC:00010 | CHEBI:2379 | DB01193 | Acebutolol | MONDO:0010138 | thyrotoxicosis | false | true | 23 |
EC:00011 | CHEBI:31159 | DB06736 | Aceclofenac | MONDO:0005306 | ankylosing spondylitis | true | false | 24 |
EC:00011 | CHEBI:31159 | DB06736 | Aceclofenac | MONDO:0005178 | osteoarthritis | true | false | 25 |
EC:00011 | CHEBI:31159 | DB06736 | Aceclofenac | MONDO:0008383 | rheumatoid arthritis | true | false | 27 |
EC:00011 | CHEBI:31159 | DB06736 | Aceclofenac | MONDO:0006898 | periarthritis | true | false | 28 |
EC:00014 | CHEBI:27690 | DB00819 | Acetazolamide | MONDO:0021811 | Acute mountain sickness | true | false | 29 |
EC:00014 | CHEBI:27690 | DB00819 | Acetazolamide | MONDO:0008223 | hypokalemic periodic paralysis | false | true | 30 |
EC:00014 | CHEBI:27690 | DB00819 | Acetazolamide | MONDO:0001817 | acute closed-angle glaucoma | true | false | 31 |
EC:00014 | CHEBI:27690 | DB00819 | Acetazolamide | MONDO:0009468 | pseudotumor cerebri | false | true | 32 |
EC:00016 | CHEBI:94688 | DB09055 | Acipimox | MONDO:0011470 | hyperlipidemia, combined, 2 | true | false | 33 |
EC:00016 | CHEBI:94688 | DB09055 | Acipimox | MONDO:0007788 | hypertriglyceridemia 1 | true | false | 35 |
EC:00017 | CHEBI:50173 | DB00459 | Acitretin | MONDO:0007417 | Darier disease | false | true | 37 |
EC:00017 | CHEBI:50173 | DB00459 | Acitretin | MONDO:0100017 | pityriasis rubra pilaris | true | false | 38 |
EC:00021 | CHEBI:83168 | DB09488 | Acrivastine | MONDO:0044212 | chronic idiopathic urticaria | true | false | 39 |
EC:00021 | CHEBI:83168 | DB09488 | Acrivastine | MONDO:0005324 | seasonal allergic rhinitis | true | false | 40 |
EC:00024 | UNII:FYS6T7F842 | DB00051 | Adalimumab | MONDO:0005306 | ankylosing spondylitis | true | false | 41 |
EC:00024 | UNII:FYS6T7F842 | DB00051 | Adalimumab | MONDO:0007191 | Behcet disease | false | true | 42 |
EC:00024 | UNII:FYS6T7F842 | DB00051 | Adalimumab | MONDO:0005011 | Crohn disease | true | false | 43 |
EC:00024 | UNII:FYS6T7F842 | DB00051 | Adalimumab | MONDO:0005532 | Crohn's colitis | true | false | 44 |
EC:00024 | UNII:FYS6T7F842 | DB00051 | Adalimumab | MONDO:0000709 | Crohn ileitis | true | false | 45 |
EC:00024 | UNII:FYS6T7F842 | DB00051 | Adalimumab | MONDO:0006559 | hidradenitis suppurativa | true | false | 46 |
EC:00024 | UNII:FYS6T7F842 | DB00051 | Adalimumab | MONDO:0011429 | juvenile idiopathic arthritis | true | false | 47 |
EC:00024 | UNII:FYS6T7F842 | DB00051 | Adalimumab | MONDO:0011849 | psoriatic arthritis | true | false | 49 |
EC:00024 | UNII:FYS6T7F842 | DB00051 | Adalimumab | MONDO:0018824 | pyoderma gangrenosum | false | true | 53 |
EC:00024 | UNII:FYS6T7F842 | DB00051 | Adalimumab | MONDO:0008383 | rheumatoid arthritis | true | false | 54 |
EC:00024 | UNII:FYS6T7F842 | DB00051 | Adalimumab | MONDO:0019338 | sarcoidosis | false | true | 61 |
EC:00024 | UNII:FYS6T7F842 | DB00051 | Adalimumab | MONDO:0005095 | spondyloarthropathy | true | false | 62 |
EC:00024 | UNII:FYS6T7F842 | DB00051 | Adalimumab | MONDO:0005101 | ulcerative colitis | true | false | 63 |
EC:00024 | UNII:FYS6T7F842 | DB00051 | Adalimumab | MONDO:0006918 | posterior uveitis | true | false | 64 |
EC:00024 | UNII:FYS6T7F842 | DB00051 | Adalimumab | MONDO:0017255 | panuveitis | true | false | 65 |
EC:00024 | UNII:FYS6T7F842 | DB00051 | Adalimumab | MONDO:0006806 | intermediate uveitis | true | false | 66 |
EC:00025 | CHEBI:31174 | DB00210 | Adapalene | MONDO:0006604 | rosacea | false | true | 68 |
EC:00029 | CHEBI:136034 | DB04931 | Afamelanotide | MONDO:0001676 | erythropoietic protoporphyria | true | false | 69 |
EC:00033 | UNII:2HLC17MX9G | DB15874 | Agalsidase beta | MONDO:0010526 | Fabry disease | true | false | 70 |
EC:00034 | CHEBI:134990 | DB06594 | Agomelatine | MONDO:0002009 | major depressive disorder | true | false | 71 |
EC:00036 | CHEBI:2549 | DB01001 | Albuterol | MONDO:0004979 | asthma | true | false | 72 |
EC:00036 | CHEBI:2549 | DB01001 | Albuterol | MONDO:0850286 | exercise-induced bronchoconstriction | true | false | 73 |
EC:00041 | UNII:3A189DH42V | DB00087 | Alemtuzumab | MONDO:0020546 | acute graft versus host disease | false | true | 74 |
EC:00041 | UNII:3A189DH42V | DB00087 | Alemtuzumab | MONDO:0015909 | aplastic anemia | false | true | 75 |
EC:00041 | UNII:3A189DH42V | DB00087 | Alemtuzumab | MONDO:0004948 | B-cell chronic lymphocytic leukemia | true | false | 76 |
EC:00041 | UNII:3A189DH42V | DB00087 | Alemtuzumab | MONDO:0015544 | acquired hemophagocytic lymphohistiocytosis associated with malignant disease | false | true | 77 |
EC:00041 | UNII:3A189DH42V | DB00087 | Alemtuzumab | MONDO:0015542 | secondary hemophagocytic lymphohistiocytosis | false | true | 79 |
EC:00041 | UNII:3A189DH42V | DB00087 | Alemtuzumab | MONDO:0015541 | hereditary hemophagocytic lymphohistiocytosis | false | true | 80 |
EC:00041 | UNII:3A189DH42V | DB00087 | Alemtuzumab | MONDO:0000452 | Progressive, relasping multiple sclerosis | true | false | 81 |
EC:00041 | UNII:3A189DH42V | DB00087 | Alemtuzumab | MONDO:0005314 | relapsing-remitting multiple sclerosis | true | false | 82 |
EC:00041 | UNII:3A189DH42V | DB00087 | Alemtuzumab | MONDO:0005301 | multiple sclerosis | true | false | 83 |
EC:00041 | UNII:3A189DH42V | DB00087 | Alemtuzumab | MONDO:0009691 | mycosis fungoides | false | true | 84 |
EC:00041 | UNII:3A189DH42V | DB00087 | Alemtuzumab | MONDO:0019469 | T-cell large granular lymphocyte leukemia | false | true | 86 |
EC:00041 | UNII:3A189DH42V | DB00087 | Alemtuzumab | MONDO:0019468 | T-cell prolymphocytic leukemia | false | true | 87 |
EC:00042 | CHEBI:2567 | DB00630 | Alendronate | MONDO:0024651 | corticosteroid-induced osteoporosis | false | true | 88 |
EC:00042 | CHEBI:2567 | DB00630 | Alendronate | MONDO:0005298 | osteoporosis | true | false | 89 |
EC:00042 | CHEBI:2567 | DB00630 | Alendronate | MONDO:0008159 | postmenopausal osteoporosis | true | false | 90 |
EC:00042 | CHEBI:2567 | DB00630 | Alendronate | MONDO:0005382 | bone Paget disease | true | false | 91 |
EC:00044 | CHEBI:51141 | DB00346 | Alfuzosin | MONDO:0010811 | benign prostatic hyperplasia | true | false | 92 |
EC:00044 | CHEBI:51141 | DB00346 | Alfuzosin | MONDO:0024647 | urolithiasis | false | true | 93 |
EC:00046 | UNII:PP0SHH6V16 | DB09302 | Alirocumab | MONDO:0018328 | homozygous familial hypercholesterolemia | true | false | 94 |
EC:00046 | UNII:PP0SHH6V16 | DB09302 | Alirocumab | MONDO:0001336 | familial hyperlipidemia | true | false | 95 |
EC:00046 | UNII:PP0SHH6V16 | DB09302 | Alirocumab | MONDO:0021187 | hyperlipidemia | true | false | 97 |
EC:00049 | CHEBI:40279 | DB00437 | Allopurinol | MONDO:0005393 | gout | true | false | 98 |
EC:00049 | CHEBI:40279 | DB00437 | Allopurinol | MONDO:0957318 | nephrolithiasis, calcium oxalate | true | false | 99 |
EC:00049 | CHEBI:40279 | DB00437 | Allopurinol | MONDO:0008171 | nephrolithiasis | false | true | 101 |
EC:00049 | CHEBI:40279 | DB00437 | Allopurinol | MONDO:0043875 | Tumor lysis syndrome | true | false | 102 |
EC:00055 | CHEBI:2611 | DB00404 | Alprazolam | MONDO:0001942 | generalized anxiety disorder | true | false | 104 |
EC:00055 | CHEBI:2611 | DB00404 | Alprazolam | MONDO:0005383 | panic disorder | true | false | 106 |
EC:00055 | CHEBI:2611 | DB00404 | Alprazolam | MONDO:0002317 | central nervous system origin vertigo | false | true | 107 |
EC:00056 | CHEBI:15544 | DB00770 | Alprostadil | MONDO:0005362 | Erectile Dysfunction | true | false | 108 |
EC:00056 | CHEBI:15544 | DB00770 | Alprostadil | MONDO:0011827 | patent ductus arteriosus | true | false | 109 |
EC:00056 | CHEBI:15544 | DB00770 | Alprostadil | MONDO:0008364 | Raynaud disease | false | true | 110 |
EC:00057 | UNII:1RXS4UE564 | DB00009 | Alteplase | MONDO:0005279 | pulmonary embolism | true | false | 111 |
EC:00057 | UNII:1RXS4UE564 | DB00009 | Alteplase | MONDO:0041656 | ST-elevation myocardial infarction | true | false | 114 |
EC:00058 | CHEBI:33130 | DB06723 | Aluminium hydroxide | MONDO:0002268 | dyspepsia | true | false | 115 |
EC:00058 | CHEBI:33130 | DB06723 | Aluminium hydroxide | MONDO:0000328 | hyperphosphatemia | true | false | 116 |
EC:00059 | CHEBI:135686 | DB06274 | Alvimopan | MONDO:0004567 | Ileus | true | false | 117 |
EC:00060 | CHEBI:2618 | DB00915 | Amantadine | MONDO:0006966 | secondary Parkinson disease | true | false | 118 |
EC:00060 | CHEBI:2618 | DB00915 | Amantadine | MONDO:0019790 | neuroleptic malignant syndrome | false | true | 119 |
EC:00060 | CHEBI:2618 | DB00915 | Amantadine | MONDO:0005180 | Parkinson disease | true | false | 120 |
EC:00060 | CHEBI:2618 | DB00915 | Amantadine | MONDO:0005391 | restless legs syndrome | false | true | 121 |
EC:00060 | CHEBI:2618 | DB00915 | Amantadine | MONDO:0010096 | tardive dyskinesia | false | true | 123 |
EC:00060 | CHEBI:2618 | DB00915 | Amantadine | MONDO:0858950 | traumatic brain injury | false | true | 124 |
EC:00061 | CHEBI:135949 | DB06403 | Ambrisentan | MONDO:0015924 | pulmonary arterial hypertension | true | false | 126 |
EC:00063 | CHEBI:135948 | DB11640 | Amifampridine | MONDO:0018556 | Lambert-Eaton myasthenic syndrome | true | false | 127 |
EC:00064 | CHEBI:2636 | DB01143 | Amifostine | MONDO:0019084 | radiation proctitis | false | true | 128 |
EC:00066 | CHEBI:2639 | DB00594 | Amiloride | MONDO:0005578 | arthritis | false | true | 129 |
EC:00066 | CHEBI:2639 | DB00594 | Amiloride | MONDO:0001134 | essential hypertension | true | false | 130 |
EC:00066 | CHEBI:2639 | DB00594 | Amiloride | MONDO:0005377 | nephrotic syndrome | false | true | 132 |
EC:00067 | UNII:41KZS5432U | DBSALT002730 | Aminobenzoate potassium | MONDO:0016367 | dermatomyositis | true | false | 133 |
EC:00069 | CHEBI:17549 | DB00855 | Aminolevulinic acid | MONDO:0043300 | Actinic cheilitis | false | true | 134 |
EC:00069 | CHEBI:17549 | DB00855 | Aminolevulinic acid | MONDO:0005173 | Actinic keratosis | true | false | 135 |
EC:00069 | CHEBI:17549 | DB00855 | Aminolevulinic acid | MONDO:0005341 | skin basal cell carcinoma | false | true | 136 |
EC:00069 | CHEBI:17549 | DB00855 | Aminolevulinic acid | MONDO:0020761 | Bowen disease of the skin | false | true | 138 |
End of preview. Expand in Data Studio
README.md exists but content is empty.
- Downloads last month
- -